scroll to top
Skip to Search
Skip to Navigation
Skip to Main Content
Skip to Footer
FAQs
Government
Non-Government
Maps & Visuals
About this Portal
Browse All
Provide Feedback
Recommend a Resource
Google Translate
Select language
English
French
German
Italian
Portuguese
Spanish
User Login
Username
*
Password
*
Administration Login
×
Google Translate
Select language
English
French
German
Italian
Portuguese
Spanish
About this Portal
Browse All
Provide Feedback
Recommend a Resource
COVID-19 Information
An Open Access Initiative
Menu
menu
FAQs
Government
Non-Government
Maps & Visuals
Site Search
Search Options
Resources and News
Resources Only
Search for US Health Departments by State
Search for US Health Departments By Zip Code
All
eBooks
Journals
Area/Country
Clinical Care
Research
News
RSS Feed
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Being ‘Socially Frail’ Comes With Health Risks for Older Adults
Fresh Produce Is an Increasingly Popular Prescription for Chronically Ill Patients
FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »
×